The reduction in insulin and IGF1 signaling, leading to a decline in the ICC and subsequent myopathy, has been identified as a key contributor to diabetic gastroparesis, distinct from the effects of hyperglycemia. The gene discussed is IGF1; the disease is intrahepatic cholangiocarcinoma.